A Real World Study to Evaluate the Effect of Nivolumab in Patients with Non Small Cell Lung Cancer: Named Patient Program (NPP)
Latest Information Update: 18 Oct 2019
At a glance
- Drugs Nivolumab (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Expanded access; Therapeutic Use
- 10 Sep 2019 Results (n=57) assessing the effect of radiotherapy prior to nivolumab in patients with advanced non small cell lung cancer, were presented at the 20th World Conference on Lung Cancer.
- 05 Jun 2018 Results assessing long term effect (survival) of nivolumab in patients with non-small cell lung cancer, presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 01 May 2017 New trial record